Radiopharm Theranostics Limited
RDPTF
$0.0113
$0.01051,312.50%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 8.99% | -9.22% | -31.75% | -47.75% | -70.67% |
| Total Depreciation and Amortization | -9.00% | -31.19% | -54.00% | -26.42% | 3.84% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -107.68% | -57.64% | 48.75% | 165.26% | 516.87% |
| Change in Net Operating Assets | 474.41% | 474.41% | 474.41% | 860.33% | -176.52% |
| Cash from Operations | -44.77% | -21.47% | 3.54% | -10.18% | -29.83% |
| Capital Expenditure | -- | -- | -- | 123.74% | 138.62% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 297.37% | 200.06% | -- | 29.74% | -151.11% |
| Cash from Investing | 301.14% | 199.53% | -- | 34.73% | -119.40% |
| Total Debt Issued | 48.37% | 296.74% | -- | 155.10% | 115.82% |
| Total Debt Repaid | -38.19% | -212.34% | -- | -- | -- |
| Issuance of Common Stock | 3,371.22% | 745.33% | 194.30% | -20.89% | -92.97% |
| Repurchase of Common Stock | -- | -- | -- | 0.00% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -5,917.06% | -1,006.10% | -130.53% | 28.86% | 92.84% |
| Cash from Financing | 3,224.06% | 751.58% | 217.94% | 69.50% | -79.21% |
| Foreign Exchange rate Adjustments | 440.11% | 37.26% | -110.39% | -87.54% | -63.78% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 253.09% | 209.40% | 144.38% | 37.11% | -153.54% |
